Form 483

Carle Reproductive Medicine Form 483, 2018-08-15

FDA issued a Form 483 to Carle Reproductive Medicine on 2018-08-15 with 2 public-safe observations.

483· Form 483 issuedBiologics2 observations

Carle Reproductive Medicine · Urbana, United States · Issued August 15, 2018

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Aug 2018
21 CFR 1271.90(c)

Eligibility not required--warning labels

Cited by Uruaku A Obasi, Neali H Lucas

15 Aug 2018
21 CFR 1271.90(c)

Eligibility not required--warning labels

Cited by Uruaku A Obasi, Neali H Lucas

Inspected site

CRCarle Reproductive MedicineUrbana, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.90(c)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere